Status:
COMPLETED
Efficacy Study of the Non-Pneumatic Anti-Shock Garment (NASG) in Egypt
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
MacArthur Foundation
Conditions:
Hypovolemic Shock
Hemorrhage
Eligibility:
FEMALE
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
This study will test the efficacy of the NASG on women suffering from obstetric hemorrhage as compared to hemorrhaging women who do not receive the NASG.
Detailed Description
This is a comparative, pre-post study of the Non-pneumatic Anti-Shock Garment (NASG) to establish its effectiveness in reducing maternal mortality and morbidity due to obstetrical hemorrhage. The site...
Eligibility Criteria
Inclusion
- blood loss from obstetric hemorrhage \>= 1000 mL
- pulse \> 100 beats per minute or systolic blood pressure \< 100 mmHg
Exclusion
- Absolute exclusion criteria:
- current viable third trimester intrauterine pregnancy that can be delivered in the next 20 minutes after hemorrhage begins
- current bleeding sites above the diaphragm.
- Relative exclusion criteria:
- history or current clinical evidence of mitral stenosis or congestive heart failure (CHF)
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
990 Patients enrolled
Trial Details
Trial ID
NCT00305253
Start Date
April 1 2006
End Date
June 1 2008
Last Update
May 14 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Assuit University Hospital
Asyut, Egypt
2
El-Galaa Teaching Hospital
Cairo, Egypt